Therapeutic Advances in Cardiovascular Disease
Therapeutic Advances in Cardiovascular Disease is a journal indexed in SJR in Cardiology and Cardiovascular Medicine and Pharmacology (medical) with an H index of 42. It is an CC BY-NC Journal with a Single blind Peer Review review system, and It has a price of 1350 €. The scope of the journal is focused on cardiology, vascular medicine, circulatory disorders, cardiac conditions. It has an SJR impact factor of 0,602 and it has a best quartile of Q2. It is published in English. It has an SJR impact factor of 0,602.
Metrics
Scimago and CountryOfPapers database fields
SJR Impact
0,602
H-index
42
Docs (year)
28
Docs 3y
40
Total refs
1506
Cites 3y
93
Citable 3y
38
Cites/Doc 2y
2.2
Ref/Doc
53.79
Immediate OA
1350 €
Embargoed OA
NPD
Non OA / Submission
- €
Name good journals. Call out predatory ones.
Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.
Researcher reviews
Best articles by citations
Metabolic syndrome: pathophysiology, management, and modulation by natural compounds
6-minute walking test: a useful tool in the management of heart failure patients
Review: Preeclampsia and future cardiovascular risk: formal risk factor or failed stress test?
ACE2 and vasoactive peptides: novel players in cardiovascular/renal remodeling and hypertension
Challenges in management of left ventricular thrombus
The emerging role of endothelin-1 in the pathogenesis of pre-eclampsia
Review: Role of the augmentation index in hypertension
Original Research: Carotid intima-media thickness and plaque volume changes following 2-year angiotensin II-receptor blockade. The Multicentre Olmesartan atherosclerosis Regression Evaluation (MORE) study
Review: Systemic and uteroplacental renin—angiotensin system in normal and pre-eclamptic pregnancies
Review: Stroke prevention: modifying risk factors
Salvianolic acid B and Tanshinone IIA attenuate myocardial ischemia injury in mice by NO production through multiple pathways
The role of cellular micronutrient analysis, nutraceuticals, vitamins, antioxidants and minerals in the prevention and treatment of hypertension and cardiovascular disease
Pathophysiology, diagnosis, and management of aortic dissection
Review: PPARs as new therapeutic targets for the treatment of cerebral ischemia/reperfusion injury
Left ventricular noncompaction cardiomyopathy: updated review
Burden of comorbidities among patients with atrial fibrillation
Review: The role of the L-arginine-nitric oxide pathway in preeclampsia
Nanomedicine applied to cardiovascular diseases: latest developments
Inflammation, depression and cardiovascular disease in women: the role of the immune system across critical reproductive events
Adiponectin gene polymorphisms and their effect on the risk of myocardial infarction and type 2 diabetes: an association study in an Italian population
Hyperglycemia in acute coronary syndromes: from mechanisms to prognostic implications